Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Week In Review: Foreseen Sells ADC Rights To France's Ipsen In $1 Billion Deal
July 13, 2024
Tickers
BMY
IPSEY
WUXIF
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Bearish Shooting Star Shines
July 13, 2024
Tickers
XBI
Tags
Pharma/Biotech
ETFs
Market News
From
TalkMarkets
Wall Street Weighs In As Pfizer Targets $100 Billion Weight Loss Market
July 11, 2024
Tickers
PFE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Market Tries To Read Between The Lines
July 10, 2024
Tickers
DIA
HYG
IBB
IWM
Tags
Transportation
ETFs
Technology
From
TalkMarkets
Will NVO Provide Any Buying Opportunity?
July 08, 2024
Tickers
NVO
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma
July 06, 2024
Tickers
AMGN
ESAIY
IVBXF
TAK
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
3 Biotech Stocks That Can Gain Exponentially By Leveraging AI
July 02, 2024
Tickers
ABCL
JANX
SKYE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
JNJ Should Rally Soon Or See 3 Swings Higher At Least
July 02, 2024
Tickers
JNJ
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Clinical-Stage BioTech Drug Stocks Declined 13% In June
July 01, 2024
Tickers
ABSI
ATAI
EXAI
MNMD
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Tickers
ABOS
ADPT
CPRX
CRMD
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary
June 30, 2024
Tickers
ASPHF
CASI
CHRS
IVBXF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses
June 28, 2024
Tickers
UTHR
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Chart Of The Day: Eli Lilly - More New Highs
June 26, 2024
Tickers
LLY
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Novo Nordisk Wins Approval For Its Weight-Loss Drug From China
June 25, 2024
Tickers
NVO
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Tickers
ABCL
ABSI
ATAI
CMPS
Tags
Technology
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal
June 22, 2024
Tickers
ABBV
DAWN
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
June 21, 2024
Tickers
LLY
NVO
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
June 17, 2024
Tickers
ABCL
EXAI
RLAY
RXRX
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Weekly Commentary: Potential Catalyst and the Q1 2024 Z.1
June 16, 2024
Tickers
AAPL
AVGO
BNOBF
CRARF
Tags
Energy
Technology
Gold/Precious Metals
From
TalkMarkets
Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare
June 15, 2024
Tickers
ASPHF
BGNE
KYKOF
SGIOF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
June 14, 2024
Tickers
ARVN
OCUP
RCKT
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Chart Of The Day: Avidity Biosciences - Something's Up?
June 14, 2024
Tickers
RNA
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
June 10, 2024
Tickers
AZN
MRK
UNH
VRTX
Tags
Market News
ETFs
Healthcare
From
TalkMarkets
In The Zone: Neurofeedback And Our Trading Impulses
June 10, 2024
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
June 10, 2024
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Technology
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
June 09, 2024
Tickers
ATAI
CMPS
GHRS
MNMD
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Tickers
AKESF
ASPHF
AVBP
AZN
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Large Cap BIopharmaceuticals Overview
June 03, 2024
Tickers
AZN
GILD
GSK
IBB
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
June 01, 2024
Tickers
AHKSF
AKESF
BAYRY
BNR
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Week In Review: Hengrui And Degron Announce $7.2 Billion In Drug Licensings
May 25, 2024
Tickers
AZN
BGNE
CSPHF
IVBXF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.